The Maryland Science Center has promoted from within to replace president and CEO Van Reiner, who will retire this year after 13 years with the Inner Harbor attraction.
Mark Potter, the organization’s vice president of development for the past six years, will assume the top spot following Reiner’s retirement in October.
A Sanofi executive discusses his company’s leadership-development programs and approach to building employee capabilities amid rapid change.
Rich Bendis, Founding President and Chief Executive Officer, BioHealth Innovation, Brian Darmody, Associate Vice President for Corporate and Foundation Relations and former Association of University Research Parks (AURP) President, and Julie Lenzer, AVP of Innovation and Economic Development at UMD engage in a discussion of the transformed university tech transfer office at the AURP BioParks 2017 conference, held in conjunction with BIO 2017 at San Diego, California.
The session was moderated by David Winwood, Associate Executive Director and Chief Business Development Officer at Pennington Biomedical Research Center at LSU, and included an earlier panel on the transformation of medical research campuses into hubs of innovation and scientific breakthroughs.
This event is a prelude to BIO 2017 in San Diego, which generated a record breaking delegation from the state of Maryland, including numerous private sector biotechnology companies based in Maryland, Ben Wu, from Maryland Department of Commerce, Tamie Howie, from the Maryland Technology Council, and biotechnology economic development representatives from across the state.
At BIO 2017 the delegation will discuss partnering opportunities with the FDA in White Oak, state financing for biotechnology companies, and presentations from Maryland’s leading biotechnology companies at the Maryland Pavilion.
Commercializing Technologies for Societal Impact
The governments of the United States of America (through the Department of State) and India (through the Department of Science & Technology) have established the United States – India Science & Technology Endowment Fund (USISTEF) for the promotion of joint activities that would lead to innovation and technopreneurship through the application of science and technology. The Endowment Fund activities are implemented and administered through the bi-national Indo-US Science and Technology Forum (IUSSTF).
The fund aims to select and financially support promising joint U.S.-India entrepreneurial initiatives that address the theme of “Commercializing Technologies for Societal Impact” through a competitive grant program.
OpGen announced today that it has signed a supply agreement with Thermo Fisher Scientific to combine its Acuitas Rapid Test for Pathogen ID with Thermo Fisher’s real-time PCR solutions.
The biotech industry remains poised for growth, EY said in its annual industry report released today, despite continuing pressure from payers to contain drug prices and an investor pullback from capital markets that helped deflate profits and slow down revenue growth for public companies last year.
“Beyond Borders: Staying the Course” observed that while biotechs will continue to pursue the prices they seek for new drugs by citing their value—either in patient outcomes or lower costs—so too will payers seek to contain those prices.
A provocative study published earlier this month in the journal Science and Public Policy contends that Europe lacks the cutting-edge science long seen in the U.S., and increasingly published in Asia: “Europe lags far behind the USA in the production of important, highly cited research,” co-authors Alonso Rodríguez-Navarro, Ph.D., of Universidad Politécnica de Madrid, and Francis Narin, Ph.D., founder of CHI Research (now The Patent Board).
Technology talent often found in California’s tech mecca Silicon Valley is starting to spread to other parts of the U.S., thanks to the rising cost of living in the Bay Area and government tax breaks for companies that move to another state. And because of that, Baltimore is starting to see growth in the industry.
“Processors are overdesigned for most applications,” says University of Illinois electrical and computer engineering professor Rakesh Kumar. It’s a well-known and necessary truth: In order to have programmability and flexibility, there’s simply going to be more stuff on a processor than any one application will use. That’s especially true of the type of ultralow power microcontrollers that drive the newest embedded computing platforms such as wearables and Internet of Things sensors. These are often running one fairly simple application and nothing else (not even an operating system), meaning that a large fraction of the circuits on a chip never, ever see a single bit of data.
The “birthplace of biotechnology” is to receive $10 million for a pioneering precision medicine programme.
It was announced this week that the California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local government’s budget, a decision welcomed by the California Life Sciences Association (CLSA).
